Overview

Learning objectives:
1. Discuss the ongoing burden and shifting epidemiology of pneumococcal disease in adults
2. Review the robust clinical trial program for an option to help address IPD in adults
3. Highlight the 2024 CDC recommendations for adult pneumococcal disease

SPONSORED BY

Merck & Co., Inc.